These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8525729)

  • 1. [Pseudomonas pseudomallei and Pseudomonas mallei--capsule-forming bacteria].
    Popov SF; Kurilov VIa; Iakovlev AT
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):32-6. PubMed ID: 8525729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
    Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
    Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunobiological properties of Burkholderia pseudomallei and Burkholderia mallei capsular substances].
    Popov SF; Tikhonov NG; Piven' NN; Avrorova IV; Viktorov DV; Kurilov VIa
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):60-4. PubMed ID: 12506631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the surface antigens of Pseudomonas pseudomallei in the pathogenesis of melioidosis].
    Piven' NN; Smirnova VI; Kapliev VI; Podzolkova GG; Khrapova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):8-12. PubMed ID: 1724862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of the causative agents of glanders and melioidosis by polymerase chain reaction].
    Tkachenko GA; Antonov VA; Zamaraev VS; Iliukhin VI
    Mol Gen Mikrobiol Virusol; 2003; (3):18-22. PubMed ID: 12966921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.
    Parthasarathy N; DeShazer D; England M; Waag DM
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):329-32. PubMed ID: 16765554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
    Galyov EE; Brett PJ; DeShazer D
    Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of Burkholderia pseudomallei and Burkholderia mallei.
    Larsen JC; Johnson NH
    Mil Med; 2009 Jun; 174(6):647-51. PubMed ID: 19585782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the type III capsular polysaccharide produced by Burkholderia pseudomallei.
    Reckseidler-Zenteno SL; Viteri DF; Moore R; Wong E; Tuanyok A; Woods DE
    J Med Microbiol; 2010 Dec; 59(Pt 12):1403-1414. PubMed ID: 20724509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phagocytability of Pseudomonas pseudomallei].
    Iliukhin VI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):130-2. PubMed ID: 665019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrastructural immunochemical study of pathogenic Burkholderia capsule].
    Piven' NN; Alekseev VV; Popov SF; Khrapova NP; Prokhvatilova EV; Viktorov DV; Plekhanova NG; Kapliev VI; Avrorova IV
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):19-24. PubMed ID: 16279528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of fluorescent liposomal immunoanalysis for the diagnostics and indication of glanders and melioidosis].
    Skopinskaia SN; Iarkov SP; Khramov EN; Khrapova NP; Piven' NN; Prokhvatilova EV
    Vestn Ross Akad Med Nauk; 2007; (12):17-22. PubMed ID: 18228662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.
    Gilad J
    Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):233-41. PubMed ID: 18221181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Capsule formation in the causative agent of glanders].
    Popov SF; Mel'nikov BI; Lagutin MP; Kurilov VIa
    Mikrobiol Zh (1978); 1991; 53(1):90-2. PubMed ID: 2067426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibodies in the differentiation of Pseudomonas mallei and Pseudomonas pseudomallei].
    Iakovleva IV; Sviridov VV; Titova NG; Khrapova NP; Lipnitskiĭ AV; Farber SM; Barkov AM
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):14-5. PubMed ID: 8553724
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular-genetic approaches to diagnosis and intraspecific typing of causative agents of glanders and melioidosis].
    Antonov VA; Iliukhin VI
    Mol Gen Mikrobiol Virusol; 2005; (2):3-9. PubMed ID: 15954468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.
    DeShazer D; Waag DM; Fritz DL; Woods DE
    Microb Pathog; 2001 May; 30(5):253-69. PubMed ID: 11373120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.